Neurocrine Biosciences (NBIX) Goodwill & Intangibles (2022 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Goodwill & Intangibles of $2.7 billion for Q2 2026, up 7229.57% year-over-year from $37.2 million in Q2 2025, and up 45343.33% on a QoQ basis from $6.0 million in Q1 2026.
Neurocrine Biosciences (NBIX) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Goodwill & Intangibles for 5 years, with the latest figure at $2.7 billion in Q2 2026.
- Goodwill & Intangibles for Q2 2026 came in at $2.7 billion, up 7229.57% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.7 billion (up 7229.57% YoY), and the FY2025 annual result was $10.8 million, down 74.41% from the prior year.
- Goodwill & Intangibles advanced to $2.7 billion in Q2 2026, from $6.0 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $2.7 billion in Q2 2026 and troughed at $6.0 million in Q1 2026.
- A 5-year average of $215.0 million and a median of $40.4 million in 2023 frame the typical range for Goodwill & Intangibles.
- The largest YoY upside for Goodwill & Intangibles was 7229.57% in 2026 against a maximum downside of 83.52% in 2026.
- A 5-year view of Goodwill & Intangibles shows it stood at $42.6 million in 2022, then decreased by 3.05% to $41.3 million in 2023, then rose by 2.18% to $42.2 million in 2024, then slumped by 74.41% to $10.8 million in 2025, then soared by 25146.3% to $2.7 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $2.7 billion in Q2 2026, $6.0 million in Q1 2026, and $10.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.73 Bn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 10.80 Mn |
| Sep 30, 2025 | 35.70 Mn |
| Jun 30, 2025 | 37.20 Mn |
| Mar 31, 2025 | 36.40 Mn |
| Dec 31, 2024 | 42.20 Mn |
| Sep 30, 2024 | 40.60 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | 41.30 Mn |
| Sep 30, 2023 | 40.40 Mn |
| Jun 30, 2023 | 42.60 Mn |
| Mar 31, 2023 | 42.80 Mn |
| Dec 31, 2022 | 42.60 Mn |